Does NIVOLUMAB Cause Dyspnoea exertional? 178 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Dyspnoea exertional have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.2% of all adverse event reports for NIVOLUMAB.
178
Reports of Dyspnoea exertional with NIVOLUMAB
0.2%
of all NIVOLUMAB reports
41
Deaths
115
Hospitalizations
How Dangerous Is Dyspnoea exertional From NIVOLUMAB?
Of the 178 reports, 41 (23.0%) resulted in death, 115 (64.6%) required hospitalization, and 11 (6.2%) were considered life-threatening.
Is Dyspnoea exertional Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 178 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Dyspnoea exertional?
TREPROSTINIL (3,378)
ALBUTEROL (2,190)
MACITENTAN (1,660)
AMBRISENTAN (1,655)
PREDNISONE (1,319)
TIOTROPIUM (1,137)
MEPOLIZUMAB (1,109)
BUDESONIDE\FORMOTEROL (1,038)
OMALIZUMAB (995)
EPOPROSTENOL (938)
Which NIVOLUMAB Alternatives Have Lower Dyspnoea exertional Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE